Clinical Trial: The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739160) titled 'The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients' on July 28.

Brief Summary: This trial will evaluate the efficacy and safety of HRS-4029 compared with placebo in participants with acute ischemic stroke (AIS).

Study Start Date: Aug. 15

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: HRS-4029

HRS-4029

DRUG: Placebo

Placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd

Published by HT Digital Content Services with permission from Health Daily Digest....